A novel, catecholamine release-inhibitory peptide from chromogranin A: autocrine control of nicotinic cholinergic-stimulated exocytosis.
Mahata
S K
SK
Department of Medicine, University of California, San Diego, USA.
Mahata
M
M
Yoo
S H
SH
Taupenot
L
L
Wu
H
H
Aroda
V R
VR
Livsey
C V
CV
Taulane
J P
JP
Goodman
M
M
Parmer
R J
RJ
O'Connor
D T
DT
D000109:Acetylcholine / Q000494:pharmacology*; D000595:Amino Acid Sequence; D000818:Animals; D002395:Catecholamines / Q000378:metabolism*; D002417:Cattle; D019439:Chromaffin Cells / Q000187:drug effects / Q000502:physiology*; D053379:Chromogranin A; D002864:Chromogranins / Q000737:chemistry / Q000494:pharmacology*; D005089:Exocytosis / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D008954:Models, Biological; D008969:Molecular Sequence Data; D009538:Nicotine / Q000494:pharmacology*; D016716:PC12 Cells; D010446:Peptide Fragments / Q000737:chemistry / Q000494:pharmacology*; D051381:Rats; D016415:Sequence Alignment
C506150:CHGA protein, human; D002395:Catecholamines; D053379:Chromogranin A; D002864:Chromogranins; D010446:Peptide Fragments; C506153:chromogranin A, rat; D009538:Nicotine; D000109:Acetylcholine